Has Abel Ramos, DO received payments from drug or device companies?

Yes. Drug and device makers reported $66,117 in general payments to Abel Ramos, DO across 15 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Abel Ramos, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Abel Ramos, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Abel Ramos, DO

Family Medicine · Glendale, CANPI 1174858583

Payments from drug & device makers

$66,117in general payments, 2019–2025

Across 15 payments — averaging $4407.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Orasure Technologies Inc.$46K
BD$20K
Vapotherm Inc$109
Johnson & Johnson$62

$540in research payments, 2019–2025

Across 1 payment — averaging $540.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

BD$540

What the payments were for

Food & beverage$171100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Orasure Technologies Inc.	9	$46,340
BD	2	$19,606
Vapotherm Inc	2	$109
Johnson & Johnson	2	$62

How this compares

$66,117 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California →

Medicare billing

Part B allowed, 2024

$44,417

Medicare patients

262

Services billed

377

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Naloxone Hcl	16	$735
Methylprednisolone	55	$297
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	36	$170
Cephalexin	43	$158
Ciprofloxacin Hcl	37	$150
Azithromycin	47	$150
Naproxen	30	$117
Ondansetron Hcl	27	$84
Metronidazole	18	$61
Tramadol Hcl	36	$55
Clonidine Hcl	18	$41
Furosemide	13	$33

Paid to pharmacies, not to this prescriber.

Other family medicine in Glendale

Esther YoonGlendale$5.8M
David HanGlendale$2.3M
Amina HaggagNorthridge$112.8M
Steven ReynoldsLong Beach$53M
Rizwana MohseniLake Forest$26.7M
Daniel JohnsonSan Diego$15.7M
Stacey LayleSan Diego$14.8M
Apinya VutikullirdCypress$14.3M
Hanid AudishSpring Valley$13.6M
Augusto FocilOxnard$12.6M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →